Rubicon Research Ltd
Pre Issue Shares
15,20,99,340
No. of Shares Issued
-
Pre Issue Equity Amt.
₹15.21 Cr
DP Filling Date
31 July 2024
Rubicon Research Ltd IPO Timeline
Rubicon Research Limited was incorporated on May 6, 1999, as a Private Limited Company under the name Rubicon Consultants Private Limited', issued by the RoC. Subsequently, the Company name was changed from Rubicon Consultants Private Limited' to Rubicon
Rubicon Research Ltd IPO Details
| Rubicon Research Ltd IPO Date | - |
| Rubicon Research Ltd IPO Face Value | - |
| Rubicon Research Ltd IPO Price | - |
| Rubicon Research Ltd IPO Lot Size | - |
| Issue Size | - |
| Fresh Issue | - |
| Offer for Sale | - |
| Issue Type | - |
| Listing At | - |
| QIB Shares Offered | - |
| Retail Shares Offered | - |
| NII (HNI) Shares Offered | - |
| Company Promoters | General Atlantic Singapore RR, Pratibha Pilgaonkar, Sudhir Dhirendra Pilgaonkar |
- Strengths
- Risks
- Opportunities
- We are the fastest growing Indian pharmaceutical company amongst our peers and the only Indian company focused completely on the US market.
- Our data-driven product selection framework has allowed us to build a product portfolio with a combination of new and specialty products allowing us to withstand pricing pressures.
- Our R&D capabilities and continuing investment allow us to pursue complex products that offer strong revenue opportunities.
- Robust sales and distribution capabilities in the US.
- Strong track record of compliance combined with expertise in cost effective manufacturing
- Experienced and entrepreneurial management team with a proven track record and marquee private equity investor.
Company Financials
Rubicon Research Ltd Financial Information (Restated)
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 03-2024 | 1,109.49 | 872.39 | 91.01 |
| 03-2023 | 867.67 | 435.87 | 12.72 |
| 03-2022 | 678.34 | 417.41 | 16.68 |
| Amount in ₹ Crore | |||
Objects of the Issue
The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
- Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by the company
- Funding inorganic growth through unidentified acquisition and other strategic initiatives and general corporate purposes
Rubicon Research Ltd IPO Prospectus
Rubicon Research Ltd IPO Listing Date
| BSE Script | - |
| NSE Symbol | - |
| Listing In | - |
| IPO Price | ₹0 |
| Face Value | ₹1 |
Company Contact Information
Medone House B-75 Road No.33Wagle Estate,Thane (West)-400604
Phone: 022 6141 4000
Email: investors@rubicon.co.in
Website: www.rubicon.co.in
Rubicon Research Ltd IPO Registrar
Rubicon Research Ltd IPO Lead Manager(s)
- Axis Capital Ltd
- IIFL Securities Ltd
- JM Financial Ltd
- SBI Capital Markets Ltd